Unable to load price data. Sorry.

¯\_(ツ)_/¯

Gentium S P A Sponsored Adr (NASDAQ OTHER:GENTY.DL)

CAPS Rating: No stars

A biopharmaceutical company engaged in the research, development and manufacture of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ OTHER:GENTY.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.81)
Submitted October 09, 2013

I may have waited too long to begin experimenting with momentum outperforms, but seeing the approach backfire could be just as useful as seeing it succeed in CAPS. I've been a long-term skeptic of Gentium, given that all their late stage trials… More

cnikigreene (< 20)
Submitted April 28, 2007

THey are not on solid ground yet.

NASDAQ OTHER:GENTY.DL VS S&P 500 (SPY)

NASDAQ OTHER:GENTY.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about GENTY.DL.

No one has written a Pitch for GENTY.DL stock yet. Tell us why you think GENTY.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in GENTY.DL.

No players have picked GENTY.DL yet. Tell us why you think GENTY.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackWedbush 88.07 3/15/2011 Outperform NS $9.00 +523.33% +43.38% +479.95 4/14/2014 @ $56.10 0 Comment
TrackBroadpointAmTech < 20 9/21/2007 Outperform NS $23.50 -61.40% -9.59% -51.82 4/17/2012 @ $9.07 0 Comment
TrackOppenheimer 50.12 8/21/2007 Outperform NS $18.75 +199.20% +25.53% +173.67 4/14/2014 @ $56.10 0 Comment

Advertisement